Fri, August 19, 2022

Salveen Richter Maintained (BLUE) at Strong Sell with Increased Target to $3 on, Aug 19th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-3-on-aug-19th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Salveen Richter of Goldman Sachs, Maintained "bluebird bio, Inc." (BLUE) at Strong Sell with Increased Target from $2 to $3 on, Aug 19th, 2022.

Salveen has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 2 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Thursday, August 18th, 2022
  • Gena Wang of "Barclays" Upgraded from Sell to Hold and Increased Target to $5 on, Friday, August 5th, 2022


These are the ratings of the 2 analyists that currently disagree with Salveen


  • Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $8 on, Tuesday, August 2nd, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 17th, 2022